| 摘要 |
<p>A drug composition for treating liver diseases, which comprises tritoqualine or its salt and one or more members selected from the group consisting of light anhydrous silicic acid, synthetic aluminum silicate, magnesium metasilicoaluminate, crystalline cellulose, cyclodextrin, and methylated cyclodextrin, as well as a process for its preparation.</p> |
